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During	1982–2007,	alveolar	echinococcosis	(AE)	was	
diagnosed	 in	407	patients	 in	France,	a	country	previously	
known to register half of all European patients. To better 
define	high-risk	groups	in	France,	we	conducted	a	national	
registry-based study to identify areas where persons were 
at	risk	and	spatial	clusters	of	cases.	We	interviewed	180	AE	
patients about their way of life and compared responses to 
those	of	517	controls.	We	found	that	almost	all	AE	patients	
lived	 in	 22	 départements in eastern and central France 
(relative	 risk	 78.63,	 95%	CI	 52.84–117.02).	 Classification	
and regression tree analysis showed that the main risk 
factor was living in AE-endemic areas. There, most at-risk 
populations	 lived	 in	 rural	 settings	 (odds	 ratio	 [OR]	 66.67,	
95%	 CI	 6.21–464.51	 for	 farmers	 and	 OR	 6.98,	 95%	 CI	
2.88–18.25	 for	 other	 persons)	 or	 gardened	 in	 nonrural	
settings	(OR	4.30,	95%	CI	1.82–10.91).	These	findings	can	
help	sensitization	campaigns	focus	on	specific	groups.	
Alveolar echinococcosis (AE) is caused by the larval stage of the fox tapeworm Echinococcus multilocu-
laris. In human infections, after a person ingests eggs, the 
metacestode cells of E. multilocularis proliferate in the 
liver, inducing a hepatic disorder mimicking liver cancer 
(1). Complete resection of liver lesions is possible in only 
one third of the cases, and parasitostatic and sometimes 
parasiticidal (2) treatment is available with benzimidazole 
compounds (albendazole or mebendazole). AE, observed 
only in the Northern Hemisphere, is linked to environmen-
tal features, such as land use for cattle breeding (pastures), 
which promotes high densities of rodents (main reservoir 
for the parasite) and thus a high prevalence of infection in 
foxes, which increases the environmental reservoir of the 
parasite (3,4). That the intermediate and final hosts of the 
parasite are members of wildlife species, largely explains 
why AE is an occupational disease of farmers and especial-
ly of cattle breeders (4). Individual risk factors vary greatly, 
however, depending on the country (1).
In Europe, the main AE-endemic areas are north of 
the Alps, primarily in Switzerland, France, Germany, and 
Austria, but recent studies showed that AE has spread 
during the past 20 years (5,6). Human AE cases have been 
diagnosed in countries previously considered free of the 
infection, such as Poland, Slovakia, Lithuania, Slovenia, 
Belgium, and Hungary (7,8). Molecular typing of E. 
multilocularis specimens collected in Europe showed that 
the European AE focus can be drawn as a core located 
in central Europe, flanked by neighboring regions where 
the parasite is less genetically diverse (6,9). In addition to 
the centrifugal spread of the disease, some epidemiologic 
studies also showed a significant trend of an increase in 
human AE incidence in some previously known foci, for 
example, in Switzerland (10). Schweiger et al. hypothesized 
that in Switzerland the increase in the fox population in rural 
and urban areas and high prevalence of E. multilocularis in 
foxes led to an increase in the infection risk for humans and 
the emergence of AE 10–15 years after infection increased 
in foxes (10).
France represents the western border of the European 
focus of AE and accounted for 235 (42%) of the 559 
patients recorded in Europe during 1982–2000 (7). Hegglin 
et al. (11) have pointed out that AE is poorly known in 
France (only 88 [17.6%] of 500 interviewed persons were 
aware of it). This study reinforced the conclusion that 
better information is needed to identify at-risk populations. 
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In particular, to avoid alarming the general population, 
we need to accurately define areas where persons are 
at risk for AE, identify exposed populations, and clarify 
behavior associated with AE contamination. Since the 
EurEchinoReg project (7), the FrancEchino Network has 
maintained a registry in France of AE cases, with the 
support of the French National Institute of Public Health 
Surveillance (Institut de Veille Sanitaire) (12). From 1982 
through 2007, this registry helped identify 407 new patients 
in France (13). We present the results of a registry-based 
study in which we aimed to better define high-risk target 
groups for prevention campaigns.
Materials and Methods
FrancEchino Registry 
Initiated by the EurEchinoReg Network, the 
FrancEchino Registry actively gathers information about AE 
patients and related data observed in France since 1982 as 
described (12). During 1997–1998, French AE patients were 
found by sending questionnaires to all hospital departments 
of medicine, radiology, and abdominal surgery that look 
after patients with AE, to all pathologists and parasitologists 
in France, and to all public hospital pharmacies that could 
deliver albendazole or mebendazole for treatment. If no 
response was received to 2 mailed questionnaires, telephone 
calls were made. Clinicians, radiologists, pathologists, 
pharmacists, and biologists were asked to report all suspected 
AE patients diagnosed since 1982, that is, patients who 
had a positive specific serologic test result, a compatible 
imaging result, characteristic histopathologic features, and 
had received albendazole or mebendazole treatment for 
>30 days. During 1998–2007, the database was updated 
every 2 years following the same procedure. Previously 
unreported patients were also identified with the support of 
national medical societies (French societies of infectious 
diseases, parasitology, gastroenterology, digestive surgery, 
and the French association for the study of the liver). All 
suspected cases were further investigated by interviewing 
physicians using a questionnaire that addressed the patient’s 
AE clinical history.
Patients were classified into the following 4 groups, 
according to the recommendations of the World Health 
Organization Informal Working Group on Echinococcosis 
(14,15): “1) possible case—any patient with compatible 
clinical and epidemiologic history and imaging findings, or 
serology positive for AE; 2) probable case—any patient with 
clinical and epidemiologic history and imaging findings, and 
serology positive for AE with 2 tests; 3) confirmed case—
the above, plus a) histopathology compatible with AE and/
or b) detection of E. multilocularis nucleic acid sequences 
in tissue obtained through surgery or percutaneous biopsy; 
4) all other patients were excluded from the study.”
Questionnaires and Data Analysis
Patients with possible, probable, or confirmed AE 
were further investigated by a questionnaire addressing 
the epidemiologic context of their infection. Questions 
explored the patient’s life, using each past address to 
search for risk factors. Six binary questions were asked 
about behavior regarding picking wild berries, eating 
raw salads, hunting, having a kitchen garden, and 
having contacts with dogs and foxes. Interviews were 
carried by telephone by a physician or during a medical 
consultation. To assess behavior of the general French 
population, these questions were also included in a 
survey conducted by Ipsos Observer (Paris, France), an 
opinion poll marketing company (Certified ISO 9001: 
2000 Bureau Véritas Certification), following the quota 
method (16). Quotas were calculated on the basis of sex, 
age (>15 years), occupation, and location, according to 
the French National Institute of Statistics and Economic 
Studies. Interviews were conducted on January 7, 2008. 
The sample size included 517 persons.
Each questionnaire contained data about age, sex, and 
socioprofessional characteristics and “commune” (smallest 
French administrative unit) of living. Nine factors were 
taken into account for analysis: the 6 above questions, 
occupation (previous occupation for retired persons), living 
in rural setting or not, and living in a département (second 
largest administrative unit in France after province) located 
in an area where persons were at risk for AE (DAR). A 
département where a cluster of cases occurred, identified 
with SaTScan software (Kulldorff, Boston, MA, USA, 
and Information Management Services, Inc., Rockville, 
Md, USA) (17), was considered a DAR. SaTScan moved 
an elliptic window of increasing diameters over the studied 
region (maximum size allowed for the smallest diameter 
was 120 km, whereas the largest diameter was not limited) 
and compared the observed AE case numbers in the window 
with the expected number under the null hypothesis, that 
is, the random location of cases among all départements. 
Statistical significance was obtained through Monte Carlo 
testing (results of the likelihood function were compared 
with 999 random replications of the dataset generated under 
the null hypothesis, following Kulldorff’s approach) (18,19).
Data were recorded anonymously by using ACCESS 
2000 (Microsoft Corp., Bellevue, WA, USA). Data 
obtained from the Ipsos Observer survey were weighted to 
reduce the bias due to the quota sampling. Incidence rates 
were referring to the mean between 1990 and 1999 national 
census. For univariate analyses, the Wilcoxon test and 
Fisher exact test were used, respectively, for quantitative 
and qualitative variable analysis.
Classification and regression tree (CART) multivariate 
analysis was used to identify behavioral groups related to 
AE risk. CART is a nonparametric and nonlinear regressive 
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approach developed in the 1980s by L. Breiman (20,21). 
CART classified persons according to the outcome 
binary variable—AE patient/non–AE patient. Among all 
covariates, CART analyzed each possible threshold to 
split the sample in 2 opposite homogeneous groups. This 
process was recursively repeated until an optimal criterion 
was reached. 
When only the main covariates were kept, the 
process enabled a tree to be built in which the terminal 
classes were groups with common behavior. Because 
behavior covariates have been known to share collinearity 
(22), CART led to the building of behavioral groups that 
avoid this bias. To quantify the relationship between the 
behavioral classes and the disease, we estimated odd ratios 
(ORs) using a logistic regression. Statistical tests and CART 
analysis were performed by using R2.13.0 (R Foundation 
for Statistical Computing; http://cran.r-project.org/).
Results
Département of residence could be accurately 
determined for 399 of the 407 patients identified by the 
FrancEchino Network. SaTScan identified 5 significant 
high risk clusters (p<0.001for each cluster), including 22 
départements. These 5 clusters have been gathered into 
2 separate at-risk areas, an area located in eastern France 
and the other in the Massif Central, where 84% and 
10% of the total of the French AE patients, respectively, 
are found (Figure 1). Taken altogether, they included 
8,900,000 inhabitants, representing 15% of the French 
metropolitan mean population for the period. In these 
areas where persons were at risk, the risk of contracting 
AE was particularly high compared to the risk in the 
rest of metropolitan France (relative risk 78.63, 95% CI 
52.84–117.02).
Because many patients who received a diagnosis of 
AE during the 1980s and the 1990s were lost to follow-up 
or had died, only part of the cohort could be interviewed. 
We obtained 180 questionnaires that could be analyzed, 
which showed 111 confirmed, 61 probable, and 8 possible 
cases. Interviewed patients were not significantly different 
(p>0.289) in terms of diagnosis status, age, sex, occupation, 
region of living, and type of commune from the whole set 
of patients, except that they were more likely to have been 
diagnosed after 1994 (p = 0.025).
Of these patients, 164 (91%) were still living in a DAR 
(Figure 1), 163 (91%) were living in the same département 
as they did 15 years before (144 [80%] in the same 
village) and 121 (67%) spent their entire life in the same 
département. Seven patients (4%) used to live in a DAR 
but had left it at diagnosis time for a median time of 11 
years (95% interquantile central interval 0.6–26.8). All 7 
used to come back into DARs every year to spend holidays. 
Altogether, the 171 patients who had lived in DARs stayed a 
median time of 56 years (95% interquantile central interval 
12.7–81.5) in DARs before the AE diagnosis was made.
Of the 9 remaining patients who never lived in a DAR, 
3 were living <50 km from the border of a DAR, 4 often 
traveled to DARs for summer holidays, and only 2 had 
little or no contact with DARs. The first person, who lived 
in Normandy (northwestern France), spent only 3 months 
in a DAR for military duty and had not been back for 34 
years, and the second person, who lived in northern France, 
occasionally traveled to DARs, but only for skiing during 
winter vacations.
Once data were weighted, the IPSOS Observer–
interviewed group (controls) accounted for 566 persons. It 
differed from the whole patient group by mean age (OR 
44.9, 95% CI 43.36–46.35 vs. 58.09, 95% CI 56.78–59.40, 
p<0.001) and geographic location (only 16% living in a 
DAR vs. 94%, OR 77.92, 95% CI 48.32–131.04, p<0.001) 
but not for sex ratio (0.92 vs. 1.07; p = 0.27). Univariate 
analysis showed a significant difference (p<0.001) between 
interviewed patients and controls for all of the following 
factors: agricultural occupation (35% vs. 5%; OR 9.58, 95% 
CI 5.82–16.06), living in DAR (91% vs. 16%; OR 52.37, 
95% CI 29.60–98.59) and in rural communes (communes 
with continuous dwellings with <2,000 inhabitants, 60% 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	19,	No.	5,	May	2013	 723
Figure	 1.	 Location	 of	 patients,	 controls,	 and	 areas	 in	 France	
where persons are at risk for alveolar echinococcosis. The main 
area for human risk is located in eastern France and includes the 
départements (second largest administrative areas in France) 
where persons are at risk for alveolar echinococcosis of clusters 
1,	2,	and	4	as	defined	by	SatScan	analysis	(Kulldorff,	Boston,	MA,	
USA,	and	Information	Management	Services,	Inc.,	Rockville,	MD,	
USA).	 Clusters	 3	 and	 5	 are	 located	 in	 the	 mountains	 of	 Massif	
Central and constitute the second area where persons are at risk.
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vs. 25%; OR 4.51, 95% CI 3.13–6.54), having a kitchen 
garden (92% vs. 63%; OR 6.98, 95% CI 3.91–13.39), 
eating raw salads (77% vs. 55%; OR 2.71,. 95% CI 1.83–
4.08), having handled a fox at least once (29% vs. 13%; OR 
2.69, 95% CI 1.76–4.09), or having a dog (81% vs. 62%; 
OR 2.59, 1.70–4.03). By contrast, the proportion of hunters 
did not differ significantly between persons with AE and 
controls (17% vs. 14%; OR 1.21, 95% CI 0.74–1.95, p = 
0.4) and those in the AE group were equally likely to eat 
raw wild berries as controls (91% vs. 91%; OR 1.04, 95% 
CI 0.57–2.04, p = 1). The subgroup analysis that compared 
patients to controls inside DARs showed similar results 
(Table 1).
Multivariate analysis with CART (Figure 2) led to a 
definition of 5 classes of persons with a significant level 
of risk. The class with the lower risk corresponded to all 
persons living outside the 22 DARs previously defined, 
whatever their habits, occupation, and site where they used 
to live (rural or urban). Compared with our reference class 
(persons living in nonrural communes inside DARs and 
having no kitchen garden), they exhibited low risk (OR 
0.097, 95% CI 0.039–0.250, p<0.001, Table 2).
Among persons who lived in a DAR, having a kitchen 
garden was associated with an increasing risk for persons 
who lived in nonrural communes (OR 4.30, 95% CI 1.82–
10.91, p = 0.004). However, the risk was higher for persons 
living in rural communes (OR 6.98, 95% CI 2.88–18.25, 
p<0.001), and among them, even higher for those with 
agricultural occupations (OR 66.67, 95% CI 6.21–464.51, 
p = 0.002).
Discussion and Conclusions
Although it has long been known that most of eastern 
France and, at a lesser degree, the Massif Central are major 
foci of AE in Europe (7), few data have been available 
concerning the specific risk factors for this disease in 
the French population. Our study confirmed that almost 
all patients with AE live in rural areas in eastern and 
central France. In addition, a heterogeneous geographic 
distribution of AE has been reported in numerous foci, 
such as in Hokkaido, Japan, where humans cases spread 
from the various areas where infected foxes were 
introduced in the 1920s (23); in the People’s Republic of 
China, where the disease is endemic to only  the western 
and northern provinces and the autonomous regions (24); 
and in other European countries such as Poland, Germany, 
Austria, and Switzerland (7). 
In our study, mapping the locations of almost all 
patients in France who received a diagnosis of AE over 
26 years and detecting clusters of patients allowed us to 
accurately identify the current areas in France where human 
AE is endemic. Less than one tenth (17/180) of the patients 
who were interviewed did not live in the same département 
at diagnosis and 15 years before, and only 5% (9/180) had 
never lived in the DARs defined by our spatial analysis. 
Taking into account the rarity of the disease in France 
(15 new patients/year until 2007) (12,13), this means that 
<1 patient per year received a diagnosis of AE among 48 
million French citizens residing outside DARs during the 
study period (mean French metropolitan population was 
57,500,000 for the study period, with only 8.9 million 
living in DARs). This low incidence of AE in most regions 
of France may have been exaggerated by misdiagnosis in 
areas where the disease is poorly known by physicians. 
However, the chronicity and the severity of the disease 
associated with the performances of diagnostic imaging 
and serologic testing, which greatly improved during the 
last decades, make a persistent misdiagnosis of AE lesions 
unlikely (25).
Because regulations in France require that albendazole 
be dispensed only in public hospital pharmacies, we can 
be reasonably confident that our detection of cases, using 
a multidisciplinary approach, was complete. Therefore, 
the clustering of almost all French cases in a few specific 
locations demonstrates the importance of the place where 
persons live and had lived in the risk assessment of AE 
and the precautions that have to be taken when generalizing 
incidence numbers to the total population. Human data 
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Table	1.	Univariate	analysis	of	studied	behavior	and	area	of	living	and risk	for	alveolar	echinococcosis,	France,	1982–2007* 
Variable 
Lived in DAR  Lived outside DARs 
No.	(%)	
patients   
No.	(%)	
controls  OR	(95%	CI) p value 
 No.	(%)	
patients   
No.	(%)	
controls OR	(95%	CI) p value 
Total no. 164 92    16 474   
Had agricultural occupation 62 (38) 7 (8) 7.33 (3.13–20.00) <0.001  1	(6) 23	(5) 1.31	(0.03–9.25) 0.558 
Had kitchen garden 152 (93) 64 (70) 5.50 (2.52–12.66) <0.001  14 (88) 292 (62) 4.35 (0.98–39.90) 0.037 
Lived	in	rural/urban	
commune 
105 (64) 27 (29) 4.26 (2.39–7.75) <0.001  3	(19) 114	(24) 0.73	(0.13–2.72) 0.772 
Had dog 133 (81) 56 (61) 2.75 (1.49–5.09) <0.001  13	(81) 297	(63) 2.58	(0.70–14.30) 0.187 
Handled	fox 50 (30) 12 (13) 2.91 (1.42–6.41) 0.002  3	(19) 64	(14) 1.48	(0.26–5.58) 0.469 
Ate raw wild salads 128	(78) 61	(66) 1.80	(0.98–3.31) 0.054  10	(63) 249	(53) 1.50	(0.49–5.12) 0.459 
Went hunting 28	(17) 15	(16) 1.06	(0.51–2.27) 1  2	(13) 65	(14) 0.90	(0.10–4.06) 1 
Ate raw wild berries 149	(91) 84	(91) 0.95	(0.33–2.50) 1  15	(94) 430	(91) 1.53	(0.23–66.05) 1 
*DAR, département (second largest administrative area in France) located in at-risk areas; OR, crude odds ratio; commune, smallest administrative unit in 
France. Boldface indicates statistical significance. 
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reflect the parasitic transmission a few years before 
diagnosis; they are not sufficient to determine the current 
situation regarding the risk of transmission and must be 
combined with frequently updated animal data.
In contrast with the highly clustered location of 
human patients, the main hosts involved in the life cycle 
of AE (foxes, dogs, voles) are found almost everywhere 
in France (26,27). Until the end of the 20th century, 
infected foxes had never been observed—but also not 
systematically searched for—outside the areas to which 
AE is endemic in humans, that is, eastern France from the 
northeastern border to the southern Alps with a limited 
focus in Massif Central (the Cantal area) (26). Our 
findings fit well with such a distribution of the infected 
foxes, although they show a substantial extension of 
the Massif Central focus toward the southeast and 
northeast. However, a recent screening campaign of the 
fox population showed the existence of infected foxes in 
northwestern France, including in Paris and its suburbs, 
and reaching the English Channel coast (Normandy 
region) (28). In our series, 2 patients from northern and 
northwestern France were found to be infected although 
they had almost never traveled to DARs. Even though AE 
prevalence in foxes is usually lower outside DARs than in 
them (leading to a lower risk for humans), these 2 patients 
could be an early indication of a broader extension of AE 
in the French population.
Notably, AE lesions develop slowly in humans, leading 
to a long period of latency between the initial infection and 
the diagnosis. Because of this latency period, AE in humans 
would increase only 10–15 years after E. multilocularis 
infection incidence increased in foxes. Such a phenomenon 
has already been observed in Switzerland (10), and 
recently Takumi et al. hypothesized that this could happen 
in the Netherlands before 2020 (29). Moreover, foxes are 
now often living in urban areas (30–32) and have a high 
incidence rate of E. multilocularis infection in some cities 
located in AE-endemic areas (30), so urban gardeners could 
have a higher risk in the future. Prevention campaigns must 
target this group in addition to rural inhabitants in regions 
where AE is endemic in humans and foxes.
Our findings identified many factors associated 
with patients’ way of life such as having an agricultural 
occupation or having a kitchen garden, 2 factors that increase 
contact with soil possibly contaminated by E. multilocularis 
eggs. Having a dog and/or handling foxes, 2 risk factors 
associated with the spread of E. multilocularis eggs by their 
main definitive hosts, were also significant variables. In 
Germany, a case-control study also found that farmers were 
at highest risk (22), whereas gardeners were found to have 
additional risk only if they grew leafy or root vegetables.
The most commonly alleged source of infection 
emphasized in public media, that is, “eating wild berries,” 
was not found to be an additional risk in our study. 
Conversely, we found that almost everyone did pick 
berries (91% in both the control and AE groups). If such 
behavior would have been a noticeable risk factor, some 
cases should have been diagnosed every year among the 
millions of the French city dwellers who go to DARs for 
hiking and tourism. In Germany, Kern et al. (22) could not 
rule out the category “eating unwashed strawberries” when 
building an individual risk score for AE. However, this 
factor was the least significant included in the score they 
developed. Similarly, our findings, as well as those of Kern 
et al., did not link AE with hunting. In contrast, a previous 
study in Austria (33) identified hunting as the most notable 
observed risk factor (OR 7.83, 95% CI 1.16–52.77). This 
Austrian study included only 21 cases, preventing he 
authors from analyzing confounding factors such as living 
in a rural area. This study did not find that owning a dog led 
to a statistical risk.
Dog ownership has been noted in many countries 
(Saint-Laurent Island, Alaska, USA [34], China [35–37], 
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Figure	 2.	 Significant	 results	 by	 multivariate	 analysis	 using	
classification	 and	 regression	 tree	 analysis	 to	 determine	 risk	 for	
alveolar	 echinoccosis	 in	 France,	 1982–2007.	 Black	 indicates	
patients; gray indicates controls; class number is enclosed in 
a	 square.	 When	 the	 last	 step	 of	 analysis	 was	 not	 significant,	
terminal classes were aggregated at the upper level. Patients 
appeared	predominant	in	4	terminal	classes:	class	1	represented	
persons who live in an urban (or semiurban) environment in a 
département (second largest administrative area in France) 
where persons are at risk for alveolar echinococcosis (DAR) and 
do	not	have	a	kitchen	garden,	class	2,	persons	who	live	in	similar	
areas	but	have	a	kitchen	garden;	class	3,	nonfarmers	who	live	in	
rural	areas	in	a	DAR;	and	class	4,	farmers	who	live	in	the	same	
environment;	 class	5,	mostly	persons	who	 live	 in	départements 
(second largest administrative areas in France) where humans 
are not at risk.
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and Turkey [38]). In Germany (22), this was a major risk 
only when persons owned dogs that “roamed outside,” 
“killed game,” or “were irregularly dewormed.” Overall, 
CART analysis was of particular interest in our process to 
determine AE risk factors. It is obvious that a person living 
in a rural area in France is more likely to own a dog, have 
a kitchen garden, and work in agriculture than a person 
living in a city. Although the method only indicates broad 
trends, CART could bypass the problem of collinearity 
between variables and allow the main profiles of persons to 
be defined on the basis of specific level of risk of infection.
In conclusion, determining who is at risk of acquiring 
AE will enable prevention campaigns to be focused on 
specific population groups. Tools and recommendations 
are already available to limit the risk of infection in 
humans (23). These tools include frequent hand washing, 
proper food handling, pet deworming, discontinuing 
vegetable gardens, and avoiding contact with foxes. 
Using bait to deworm foxes has also been proposed (30). 
Because AE remains mostly clustered in geographically 
distinct areas (and persons who spend only vacation time 
in these AE-endemic areas do not appear at high risk), 
sensitization campaigns should be aimed at persons who 
live in AE-endemic areas, especially those who have an 
agricultural occupation, have a garden, or live in rural 
settings. Local outlets, such as rural medical offices, 
pharmacies, and communal administrative information 
bulletins as well as local newspapers and radio and TV 
channels could convey awareness messages. Placing 
general advertisements in national media might be 
counterproductive by alarming persons not at risk for 
the disease and by focusing on the most sensational or 
supersensitive information (such as the potential danger 
of wild berries) (39,40), while overlooking more obvious 
measures to avoid contamination, such as pet deworming 
and hand washing after gardening or playing with pets. 
Nevertheless, the situation might change, and screening 
for human AE cases and continuous monitoring of fox 
infections could enable this strategy to be adapted to new 
foci as necessary. 
Additional members of the FrancEchino Network who contrib-
uted data: V. Vitrat (Hospital Center, Annecy); B. Bartholomot, I. 
Beurton-Chataigner, O. Blagosklonov, M.P. Brientini, S. Cappelle, 
E. Delabrousse, V. Di Martino, S. Evrard, S. Felix, F. Grenouillet, 
B. Heyd, B. Kantelip, S. Koch, G. Mantion, L. Millon, C. Richou, 
C. Vanlemmens (University Hospital, Besançon); P. Giraudoux, F. 
Raoul, D. Vuitton (Franche-Comté University, Besançon); P. Prost 
(Hospital Center, Bourg-en-Bresse); C. Godet (Hospital Center, 
Charleville Mezière); M. Cambon (University Hospital, Clermont-
Ferrand); J.F. Besancenot, B. Cusenier, P. Hillon, A. Minello 
(University Hospital, Dijon); O. Faure, C. Letoublon (University 
Hospital, Grenoble); O. Guillaud, C. Partensky, M. Rabodonirina, 
M. Wallon (University Hospital, Lyon); E. Chatelain, M. Johann, 
J.J. Raabe (Hospital Center, Metz); D. Sondag (Hospital Center, 
Mulhouse); L. Letranchant, M. Machouart (University Hospital, 
Nancy); O. Farges, D. Samuel (Assistance Publique–Hôpitaux de 
Paris, Paris); C. Chemla, J.F. Delattre (University Hospital, Reims); 
B. Guerin (Hospital Center, Rodez); M. Debruyne (Cerba, Saint-
Ouen-L’Aumone); A. Abou-Bacar, M. Audet, Y. Hansmann, N. 
Lefebvre (University Hospital, Strasbourg); V. Li (Hospital Center, 
Thonon); B. Alby-Lepresle (Hospital Center, Vesoul).
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